2 days Wall Street Analysts Think ImmunityBio (IBRX) Could Surge 184.43%: Read This Before Placing a BetZacks
The average of price targets set by Wall Street analysts indicates a potential upside of 184.4% in ImmunityBio (IBRX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
X